Abstract:ABSTRACT Between 2016 and 2018, Brazil experienced major sylvatic yellow fever (YF) outbreaks that caused hundreds of casualties, with Minas Gerais (MG) being the most affected state. These outbreaks provided a unique opportunity to assess the immune response triggered by the wild-type (WT) yellow fever virus (YFV) in humans. The plaque reduction neutralization test (PRNT) is currently the standard method to assess the humoral immune response to YFV by measuring neutralizing antibodies (nAbs). The present study aimed to evaluate the humoral immune response of patients from the 2017–2018 sylvatic YF outbreak in MG with different disease outcomes by using PRNTs with a WT YFV strain, isolated from the 2017–2018 outbreak, and a vaccine YFV strain. Samples from naturally infected YF patients were tested, in comparison with healthy vaccinees. Results showed that both groups presented different levels of nAb against the WT and vaccine strains, and the levels of neutralization against the strains varied homotypically and heterotypically. Results based on the geometric mean titers (GMTs) suggest that the humoral immune response after a natural infection of YFV can reach higher levels than that induced by vaccination (GMT of patients against WT YFV compared to GMT of vaccinees, P < 0.0001). These findings suggest that the humoral immune responses triggered by the vaccine and WT strains of YFV are different, possibly due to genetic and antigenic differences between these viruses. Therefore, current means of assessing the immune response in naturally infected YF individuals and immunological surveillance methods in areas with intense viral circulation may need to be updated. IMPORTANCE Yellow fever is a deadly febrile disease caused by the YFV. Despite the existence of effective vaccines, this disease still represents a public health concern worldwide. Much is known about the immune response against the vaccine strains of the YFV, but recent studies have shown that it differs from that induced by WT strains. The extent of this difference and the mechanisms behind it are still unclear. Thus, studies aimed to better understand the immune response against this virus are relevant and necessary. The present study evaluated levels of neutralizing antibodies of yellow fever patients from recent outbreaks in Brazil, in comparison with healthy vaccinees, using plaque reduction neutralization tests with WT and vaccine YFV strains. Results showed that the humoral immune response in naturally infected patients was higher than that induced by vaccination, thus providing new insights into the immune response triggered against these viruses.

Possible non-sylvatic transmission of yellow fever between non-human primates in São Paulo city, Brazil, 2017–2018

Investigation of Yellow Fever Virus at the Human–Animal Interface after a Zika Virus Outbreak in Midwest Brazil

Survey on Non-Human Primates and Mosquitoes Does not Provide Evidences of Spillover/Spillback between the Urban and Sylvatic Cycles of Yellow Fever and Zika Viruses Following Severe Outbreaks in Southeast Brazil

Exploring environmental and climate features associated with yellow fever across space and time in the Brazilian Atlantic Forest biome

Yellow Fever Virus Maintained by Sabethes Mosquitoes during the Dry Season in Cerrado, a Semiarid Region of Brazil, in 2021

Genomic and epidemiological monitoring of yellow fever virus transmission potential

Yellow Fever Emergence: Role of Heterologous Flavivirus Immunity in Preventing Urban Transmission

Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017–2018 sylvatic outbreak in Brazil

Ecological Requirements for Abundance and Dispersion of Brazilian Yellow Fever Vectors in Tropical Areas

Mitochondrial DNA Sequencing and BLAST Analysis Reveal Visual Misidentification of Nonhuman Primates Suspected to have Died of Yellow Fever in Brazil in 2017–2020

Correction: Garcia-Oliveira et al. YELLOW ALERT: Persistent Yellow Fever Virus Circulation among Non-Human Primates in Urban Areas of Minas Gerais State, Brazil (2021–2023). Viruses 2024, 16, 31

Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients

Development and validation of RT-LAMP for detecting yellow fever virus in non-human primates samples from Brazil

Coinfection with Canine Distemper Virus and Yellow Fever Virus in a Neotropical Primate in Brazil

Modelling the transmission and spread of yellow fever in forest landscapes with different spatial configurations

Human biting activity, resting behavior and yellow fever virus transmission potential of Aedes mosquitoes in southwest Ethiopia

Yellow fever disease severity and endothelial dysfunction are associated with elevated serum levels of viral NS1 protein and syndecan-1

Evaluating vector competence for Yellow fever in the Caribbean

Entomological investigations into yellow fever outbreak in northern Ghana

Aedes mosquitoes in the emerging threat of urban yellow fever transmission

Phylogenomic Analysis Unravels Evolution of Yellow Fever Virus Within Hosts.